Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cutaneous solution spray |
Is a |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
karbolfuksinlösning för lokalt bruk |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
Clotrimazole 10 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely nitrofural 2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely erythromycin 15 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Efinaconazole 100 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely hydrogen peroxide 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Hydrogen peroxide 300 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine diacetate 200 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Chlorhexidine gluconate 1 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine diacetate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Chlorhexidine gluconate 500 microgram/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely phenol 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely phenol 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely dyclonine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
klindamycinfosfat 10 milligram/milliliter, kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Aminolevulinic acid hydrochloride 200 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Diclofenac sodium 15 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely tetracycline hydrochloride 2.2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 20 milligram/1 gram conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 260 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely glutaraldehyde 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Podophyllotoxin 5 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely benzalkonium chloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely benzalkonium chloride 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Cetrimide 10 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
cetrimid 5 milligram/milliliter och klorhexidinglukonat (som klorhexidin) 500 mikrogram/milliliter, kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Methylrosanilinium chloride 10 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Potassium permanganate 1 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely silver nitrate 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Silver nitrate 250 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely silver nitrate 400 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Silver nitrate 500 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely sodium chloride 9 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
klorhexidinglukonat 0,5 % i 70 % IMS, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
klorhexidinglukonat 0,5 % / natriumnitrit 0,1 % i 70 % IMS, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
lidokainhydroklorid 2 %, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely sulconazole nitrate 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
ciklopiroxolamin 8 %, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
Haloprogin 10 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone butyrate 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely Podophyllum resin 250 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
fluorouracil 1 %, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely halcinonide 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely hydroquinone 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Terbinafine (as terbinafine hydrochloride) 10 mg/g cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Aluminium chloride 250 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely fluocinonide 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely ciclopirox 80 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Fluorouracil 20 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
fluorouracil 5 %, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely mequinol 20 milligram/1 milliliter and tretinoin 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
klorhexidinglukonat 1 % + etylalkohol 61 %, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
natriumhypoklorit 0,5 %, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
jod 0,7 %/isopropanol 74 vikt per vikt, lösning för lokalt bruk |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
Aluminium chloride 200 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Cetrimide 200 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely adapalene 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Cetrimide 400 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Chlorhexidine gluconate 50 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
kokain 10 %, viskös kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
kokain 4 %, viskös kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Povidone iodine 40 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
natriumhypoklorit 8 %, kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
Sodium hypochlorite 10 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
koltjära 40 %, kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
rekombinant trombin 20 000 IE, pulver till kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
bovint trombin 20 000 IE, pulver till kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
bovint trombin 5 000 IE, pulver till kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
rekombinant trombin 5 000 IE, pulver till kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
Tioconazole 283 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Tetracaine hydrochloride 5 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Benzocaine 200 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Dexamethasone 1 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Solution for iontophoresis |
Is a |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Product containing precisely coal tar 300 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Cocaine hydrochloride 40 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Triclosan 20 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Coal tar 100 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Salicylic acid 170 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
Tretinoin 500 microgram/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
amorolfinhydroklorid 50 milligram/milliliter, kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|